Skip to content
Forensic Analysis · Live Entertainment & Events · as of Nov 9, 2026

All In FutureTech Alliance, Inc. (AIFA)

A forensic read on All In FutureTech Alliance, Inc. built from its complete SEC filings — financial-health screens, earnings quality, red flags and a price-aware rating. Reproducible math, not opinion.

D · Weak — demands caution
Forensic grade
Distress
Financial health
-6.2
Distress distance
Clean
Earnings quality
5
Forensic signals
-60.8%
ROE
-12.2%
Revenue growth

This free snapshot doesn't read filing or proxy text, so the auditor-quality and governance checks that can lower a grade were not evaluated (auditor quality, say on pay, board independence, going concern). Those checks only ever lower a grade, so the full analysis can land below the grade above but never above it — treat it as the most favourable reading, not the settled one.

All In FutureTech Alliance, Inc. earns a D (Weak — demands caution) forensic quality grade, and its balance-sheet distress test reads -6.2, placing it in the Distress zone. 5 forensic signals were flagged in its latest SEC filings, led by return on invested capital.

What the filings flag

-111.0%
FY2025
Return on invested capital. Return on invested capital is -111.0% in the latest fiscal year and slipping across FY2023–FY2025 from -6.2%. After-tax operating profit was ($5M) in FY2023 and ($31M) in FY2025, with operating income at -86.2% of revenue in FY2023, -256.7% in FY2024 and -489.7% in FY2025. The capital base behind it came down -67% across FY2023–FY2025, from $84M to $28M, so this return is struck on a smaller base than it started on. $23M of the $28M base at FY2025 is short-term investments (83.5%) — securities held beside cash, which the base keeps because only cash is subtracted from it; they earn the balance sheet's yield, which is not in the operating profit above, so the loss on the operating capital is larger than this rate shows. FY2025's operating profit carried a $7M asset write-down and a $668,818 goodwill write-off that alone took about 22.5 points off that year's return, so about 22.5 of the 104.8-point fall across FY2023–FY2025 is that charge landing in the latest year rather than the capital earning less. FY2024's operating profit carried a $10M goodwill write-off and a $357,826 asset write-down that alone took about 14.1 points off that year's return; FY2024 sits between the two ends of FY2023–FY2025, so the charge shapes the path between them without moving the change across it. A non-cash write-down lowers the reported return in the year it lands.
+13.3%
FY2024→FY2025
Accruals ratio (% of NOA). Net operating assets grew +13.3% relative to their own average in FY2025 — scaled by NOA itself, not by total assets, which is what the Forensic Screens card's own accrual row divides by. Accruals are building faster than is comfortable — part of profit is sitting in the balance sheet rather than turning to cash. A cash-flow measure on the same base disagrees: reported earnings ran behind operating cash by 95% of net operating assets, against an accruals ratio of 13.3%. The two are computed differently: the accruals ratio is the change in net operating assets over average net operating assets, while the cash-flow figure is net income less operating cash flow over that same average. Read them as two results, not one.Accruals ratio: the year-over-year change in net operating assets, relative to their own average.NOA (net operating assets): the money tied up in running the business, operating assets minus operating liabilities.
+3.1%/yr
FY2023–FY2025
Share-count dilution. Diluted share count changed +6% over the last 2 years to FY2025 (+3.1%/yr). The count is growing — 37.2M shares in FY2023, 39.6M in FY2025: more stock was issued than repurchased over this window, so aggregate results grew faster than their per-share equivalents. That's ~3.1% shaved off per-share growth every year — total profit has to grow that much just to keep earnings-per-share flat, and a stake held since FY2023 has been diluted ~6%.
6% of rev
FY2025
Stock-based comp load. Stock-based compensation ran 6% of revenue in FY2025 — about $0.01 per diluted share. No cash left the business to pay it, which is why operating cash flow adds it back. Net of repurchases the diluted count still rose about 3.1% a year across FY2023–FY2025, and the rate is falling. Stock compensation is one source of that issuance; acquisition consideration, equity raises, convertibles and other employee plans also net into the count, and these figures do not separate them.
$10M
FY2024–FY2025
Goodwill impairments. Took $10M of goodwill writedowns across 2 years (FY2024 ($10M), FY2025 ($668,818)). Writedowns mean past acquisitions underperformed what was paid for them.

Key fundamentals

Latest Revenue$8.0M
Revenue Growth YoY-12.2%
Revenue CAGR (2yr)+2.1%
Net Margin-411.1%
Free Cash Flow-$9.9M
Return on Equity-60.8%

The forensic grade and screens above are free — no account needed. Want the AI investment read on top — the 0–100 rating, thesis, bull-vs-bear, red flags and the 12-month scenario, written from All In FutureTech Alliance, Inc.'s actual 10-K/10-Q/8-K filings?

Generate the AI investment read →

No credit card · informational only, not investment advice · see the track record

← Browse all forensic stock analyses

Data from SEC EDGAR public filings · metrics as of Nov 9, 2026. Forensic signals flag probability, not certainty.

See a wrong number? Report an error with the filing it should match.